Skip to main content
editorial
. 2014 Dec;3(6):410–414. doi: 10.3978/j.issn.2304-3881.2014.07.06

Table 2. Diagnostic and prognostic value of serum N-glycans following primary curative hepatectomy for hepatocellular carcinoma (22).

Performance characteristic† G2890 G3560
Sensitivity 82.7% 71.3%
Specificity 92.3% 88.5%
ROC-AUC 0.91 0.85
Overall survival (HR, 95% CI) − 2.5 (1.6-3.9)
Disease-free survival (HR, 95% CI) 1.4 (1.1-1.9) −

†, sensitivity, specificity, and ROC-AUC data based on diagnosis of HCC vs. controls; overall and disease-free survival data obtained through multivariate analysis. AUC, area under the curve; CI, confidence interval; HCC, hepatocellular carcinoma; HR, hazard ratio; ROC, receiver operating characteristic.